Validation of the BioIntelliSense BioButton® device for physical activity monitoring in children and future application as a physical health outcome for critically Ill children

验证 BioIntelliSense BioButton® 设备在儿童身体活动监测中的应用,以及其未来作为危重儿童身体健康状况评估指标的应用前景

阅读:1

Abstract

INTRODUCTION: Mobile monitoring devices offer an opportunity to characterize physical health recovery in children who survive critical illness. METHODS: To validate the BioIntelliSense BioButton® as a pediatric activity monitor, we studied healthy children (2-17 years-old) who wore the BioButton® device and an ActiGraph wGT3X-BT accelerometer, and a study team member documented activity in 1 min intervals (gold standard) during 45 min of scripted activities. In two-thirds of the cohort (derivation cohort), we identified BioButton activity count thresholds to differentiate activity levels based on highest Youden indices. Thresholds were applied to the remainder of the cohort (validation cohort) to determine sensitivity and specificity [95% confidence interval (CI)]. We also evaluated BioButton activity designations compared with accelerometer designations and calculated agreement between BioButton-measured body position and the activity log. RESULTS: Forty-five participants provided a median 43 (IQR 41, 44) analyzable minutes. Sensitivity and specificity of derived BioButton thresholds were 0.78 (95% CI: 0.69, 0.88) and 0.95 (95% CI: 0.90, 0.97) to identify moderate or vigorous activity (MVPA) and 0.91 (95% CI: 0.87, 0.95) and 0.98 (95% CI: 0.98, 0.98) to identify sedentary behavior. Sensitivity and specificity compared with the accelerometer were 0.52 (95% CI: 0.45-0.60) and 0.88 (95% CI: (95% CI: 0.84, 0.93) to identify MVPA and 0.92 (95% CI: 0.89-0.96) and 0.70 (95% CI: 0.67, 0.73) to identify sedentary behavior. The BioButton accurately identified position during 1,125 of 1,432 (78.6%) minutes. DISCUSSION: The BioButton device accurately identified physical activity and body position in children and may be a useful tool to quantify physical activity as an outcome in future trials.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。